3,3-spiroindolinone derivatives

Details for Australian Patent Application No. 2008253154 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Liu, Jin-Jun; Zhang, Zhuming; Tilley, Jefferson Wright

Agent Davies Collison Cave

Pub. Number AU-A-2008253154

PCT Pub. Number WO2008/141917

Priority 60/938,494 17.05.07 US

Filing date 6 May 2008

Wipo publication date 27 November 2008

International Classifications

C07D 487/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/141917 Priority application(s): WO2008/141917

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008253168-Module for electric energy storage assemblies for ageing detection of said assemblies

2008253134-Composition useful for the prevention of adverse effect due to the use of PPARgamma agonists